On‑the‑go treatment with a 5‑minute injection time1

UDENYCA® may reduce the risk of febrile neutropenia while providing more administration options to meet the needs of your patients and practice

Image of UDENYCA® on-body injector

High-quality, well-tolerated adhesive*2

Translucent window with black fill indicator against a white background

Metal medicine port and green fill guide support proper filling

Status light indicates if device is working properly

*Uses acrylic adhesive. For patients who have reactions to acrylic adhesives, use of this product may result in a significant reaction.3

Image of UDENYCA® on-body injector

See the UDENYCA on‑body injector in action

For complete application information, please see the Instructions for Use.

Turn your phone sideways for an ideal viewing experience.

Discover the UDENYCA on‑body injector1,3

Injection time


Injection modality

Needle inserted at time of injection and
remains inserted for only 5 minutes

Needle retraction

Automatic retraction of needle after delivery

Fill indicator

Solid black indicator moves against a white background


Large surface area with well-tolerated adhesive2

Help prevent febrile neutropenia in 4 steps1

For complete application information and instructions on how to use the UDENYCA on-body injector, please see the Instructions for Use.

Prepare the application site

Graphic of the UDENYCA® application site

Get the device ready

Graphic on how to prepare the on-body injector

Apply the injector

Graphic of the on-body injector being applied

Review important information with your patient

Image of doctor and patient


UDENYCA was demonstrated to be highly similar to Neulasta®, with no clinically meaningful differences.3,4

Discover the value of UDENYCA


UDENYCA Solutions provides support services designed to ensure every patient has access to treatment.

Discover patient support


Sign up to receive information regarding key topics like reimbursement, patient support services, and more.

Sign up

References: 1. UDENYCA ONBODY HCP Instructions for Use. Redwood City, CA: Coherus BioSciences, Inc.; 2023. 2. Data on file. Coherus BioSciences, Inc.; 2023. 3. UDENYCA (pegfilgrastim-cbqv) Prescribing Information. Redwood City, CA: Coherus BioSciences, Inc.; 2023. 4. Neulasta® (pegfilgrastim) Prescribing Information. Thousand Oaks, CA: Amgen Inc.; 2021.